Why reconstruction fixes the ligament but not the joint

Having an ACL reconstruction and then watching the knee continue to deteriorate years later is one of the most common — and most under-explained — experiences in orthopaedic care. The reason is straightforward: the surgery fixes the ligament. It does not fix the joint.

These are two separate biological problems. Reconstruction restores mechanical stability by replacing the torn ligament with a graft, and it does that job well. But the cartilage lining the joint surfaces is a different tissue entirely, governed by different biology, and it does not benefit from ligament repair in any direct way.

The damage to cartilage often begins at the exact moment of injury — the same pivot-shift event that ruptures the ligament also delivers a compressive force to the articular surfaces, leaving changes that are invisible to the naked eye but detectable on MRI. That early damage can be present when the patient goes into surgery, and the surgical procedure itself introduces a further biological stress to the joint environment. Neither is reversed by successful graft fixation.

This is not a failure of surgery. It is a limitation of what surgery was designed to do. Many patients are not clearly told this at the time of reconstruction, which is why pain and stiffness appearing five or ten years later can feel inexplicable. Understanding that two separate processes were set in motion at the moment of injury is the starting point for making sense of what comes next.

Two ways ACL injury damages cartilage

Two injury events happen in rapid succession when the ACL tears: a mechanical one and a biological one. Each drives a separate strand of cartilage damage, and they operate on very different timescales.

The acute impact

At the moment of the pivot-shift, the lateral femoral condyle and tibial plateau are driven against each other with considerable force. The result is subchondral bone bruising — trabecular microfractures in the bone immediately beneath the cartilage surface, concentrated in the lateral compartment. Slauterbeck and colleagues mapped this pattern in 2009, showing that cartilage and meniscus lesions associated with ACL tears follow anatomically predictable distributions, with the lateral compartment bearing the brunt of the initial load.

The concern is what happens next. Radin and Rose established that subchondral bone is not passive scaffolding: changes in its stiffness and architecture actively initiate and propagate damage to the cartilage above. That said, definitive longitudinal data tracking MRI bone-bruise signal to confirmed cartilage erosion remain limited. The mechanistic link is plausible and supported by indirect evidence — it is not a certainty in every case.

Chronic mechanical wear

Even after successful reconstruction, loading patterns across the joint may remain subtly abnormal — particularly during rehabilitation and in patients who return to pivoting activity before neuromuscular control is fully restored. This aberrant loading gradually degrades the cartilage surface in a way that is different in character from the acute impact: slower, cumulative, and distributed across a broader area.

At the cellular level, mechanical injury accelerates chondrocyte senescence, causing cartilage cells to stop renewing themselves prematurely and reducing the joint's capacity for self-repair. Research has also implicated mitochondrial stress pathways — reactive oxygen species in particular — as amplifiers of both the acute and the chronic phases of damage.

Which factor is the dominant long-term driver — the initial impact, ongoing instability, or the underlying cellular biology — remains an open question in the research literature. In practice, all three are likely to interact.

How common is long-term joint damage, and when does it appear

The risk of developing osteoarthritis after an ACL injury is not fixed — it depends heavily on what else was damaged at the same time.

For isolated ACL tears, long-term OA prevalence in follow-up studies ranges from 0 to 13%. That is lower than most patients anticipate. The more important number, however, belongs to the much larger group: roughly 80% of ACL injuries involve a concurrent meniscal tear, and in those patients the OA prevalence rises sharply to 21–48%. The meniscus is not incidental to this story — it is arguably the central variable.

The timeline adds a further layer of difficulty. Radiographic OA has been documented across multiple long-term cohort studies at the 10–15-year mark after reconstruction — a span that means many patients feel well for years before structural decline becomes apparent. The Lohmander 2004 cohort put a specific figure on that decline; what matters here is the timing: damage accrues quietly, and symptoms frequently lag behind structural change by months or years. A knee that feels reasonable at the five-year review may look quite different on imaging at twelve.

The population scale of this problem is considerable. More than 200,000 ACL injuries occur annually in the United States alone. Applied across that volume, even a modest OA prevalence in the isolated-tear group represents a substantial clinical burden; in the combined ACL-and-meniscus group, the numbers become striking.

For any individual patient, the relevant modifying factors are meniscal integrity, sport and loading level, and the quality of long-term rehabilitation — not simply whether reconstruction was performed.

Which parts of the knee are most vulnerable

Cartilage damage after ACL injury is not randomly distributed across the joint — it clusters on specific surfaces in a pattern that has direct implications for imaging, monitoring, and any future focal repair.

The outer side of the knee (the lateral compartment) takes the greatest initial hit. The pivot-shift force drives the lateral femoral condyle and tibial plateau against each other, and it is these surfaces that show the highest concentration of acute cartilage and meniscus lesions. Slauterbeck and colleagues (2009) formalised this observation through geographic mapping of lesion locations in ACL-injured knees, confirming that the lateral compartment is where damage is most reliably found in the immediate aftermath of injury.

The inner side of the knee (the medial compartment) follows a different and slower trajectory. Medial cartilage damage tends to accumulate over years rather than appearing at the time of injury, driven by altered loading patterns that shift mechanical stress progressively as instability — subtle or otherwise — persists. A scan taken shortly after reconstruction may therefore underrepresent where degeneration will eventually settle.

Meniscal tears reinforce this compartment-by-compartment progression. The lateral meniscus is most exposed at the point of injury, whilst the medial meniscus faces increasing mechanical demand as the joint adapts over time. Each compromised meniscus withdraws a layer of cushioning from the cartilage beneath it.

For the assessing specialist, this predictable geography shapes decisions: which compartments to examine closely on MRI, where to direct image-guided assessment, and — when a focal approach becomes appropriate — which surfaces warrant closest attention.

Treatment options across the damage spectrum

The treatment options available after ACL-related cartilage damage depend almost entirely on how far along the damage spectrum a patient sits when they present for assessment.

Conservative care remains the foundation at every stage. Physiotherapy aimed at restoring muscle balance and joint loading patterns, activity modification, and anti-inflammatory support form the first response to early post-traumatic symptoms. For many patients in the months following reconstruction, this is sufficient to manage day-to-day function while the joint stabilises — and it remains relevant even as other treatments are added.

Focal surgical repair becomes an option when imaging shows a contained defect with intact margins and healthy surrounding cartilage. Microfracture and mosaicplasty are established theatre-based procedures for smaller lesions, generally under 2–4 cm². For defects of 3 cm² or larger, matrix-induced autologous chondrocyte implantation (MACI) showed improved KOOS pain and function scores at both two and five years compared with microfracture in the SUMMIT trial. Both options rely on a margin of healthy tissue from which the repair can build.

Injectable biological support sits in a distinct part of the pathway — suitable for patients with focal defects where surgery is not yet indicated, or where an outpatient approach is clinically appropriate. Collagen scaffold pathways work by providing a matrix that recruits the body's own progenitor cells to support cartilage repair. ChondroFiller, for example, is delivered as an ultrasound-guided injection in an outpatient setting — a different category from theatre-based procedures and a different mechanism from symptom-management injections such as corticosteroid or hyaluronic acid, each of which serves a separate purpose in the joint.

The clinical gap opens when damage becomes diffuse. Once degeneration has spread across multiple surfaces and the healthy cartilage borders are lost, focal tools — injectable or surgical — have nothing sound to anchor to. This is the point at which the treatment ladder runs out before joint replacement becomes appropriate. Patients in their 40s and 50s are disproportionately affected: the damage is often too extensive for focal repair, yet they remain too young and too active for a prosthesis to be the right answer.

When to seek a specialist assessment

Persistent pain, swelling after activity, a catching or locking sensation, stiffness that takes more than a few minutes to ease after rest, or a loss of confidence on stairs and uneven ground — none of these are simply part of growing older after an ACL reconstruction. Each is a signal that the joint warrants a structured look.

Specialist assessment does not commit a patient to surgery. For many, it maps the current state of the joint and opens conservative or biologic options that remain viable precisely because the patient acted early. Once damage becomes diffuse, those choices narrow — which is why timing matters.

Imaging (a weight-bearing X-ray alongside MRI) helps establish the extent and location of damage; findings are most useful when interpreted alongside symptoms and function, not as a standalone verdict.

The most important take-away from this article is straightforward: new or worsening joint symptoms years after reconstruction deserve investigation now, not when they become severe. Given everything covered above — the acute cartilage injury at the moment of the pivot-shift, the slow drift of loading patterns, the narrowing of repair options as damage spreads — early assessment is the single point in the timeline where the broadest range of responses is still available.

Specialist assessment in London

Liquid Cartilage™ is available in the UK at the London Cartilage Clinic on Harley Street. Patients wishing to explore whether a collagen scaffold approach is suitable can book an assessment via londoncartilage.com.